Transition Therapeutics, Inc. (TTHI) Earnings
|
Expand Research on TTHI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -30.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/16  |
 |
Q316 | -CDN$0.11 | N/A | N/A | N/A | N/A | N/A |  | | Details |
| 2/9/16 |
|
Q216 | -$0.17 | N/A | N/A | N/A | N/A | N/A | | | Details |
| 11/10/15 |
|
Q116 | -$0.12 | N/A | N/A | N/A | N/A | N/A | | | Details |
| 9/15/15 |
|
Q415 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | |
| 5/12/15 |
|
Q315 | -CDN$0.13 | N/A | N/A | N/A | N/A | N/A | | | Details |
| 11/12/14 | Q312 | -$0.45 | -$0.18 | -$0.27 | N/A | N/A | N/A | | | Details | |
| 2/9/12 |
|
Q212 | -$0.15 | N/A | N/A | N/A | $9.4M | N/A | | | Details |
| 12/1/11 |
|
Q112 | -$0.12 | N/A | N/A | N/A | N/A | N/A | | | Details |
